Severe fibrotic changes and altered expression of angiogenic factors in maternal scleroderma: Placental findings

Annals of the Rheumatic Diseases

Volumn 69, Issue 2, 2010, Pages 458-461

  Ibba Manneschi, L ^a   Manetti, M ^a   Milia, A F ^a   Miniati, I ^a   Benelli, G ^a   Guiducci, S ^a   Mecacci, F ^a   Mello, G ^a   Di Lollo, S ^a   Matucci Cerinic, M ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; ANGIOGENIC FACTOR; CONNECTIVE TISSUE GROWTH FACTOR; HEMATOXYLIN; PHOSPHOTUNGSTIC ACID; PLACENTAL GROWTH FACTOR; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2;

ADULT; ARTICLE; CASE REPORT; CONTROLLED STUDY; FEMALE; FIBROSIS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PLACENTA; PREGNANCY; PREMATURE LABOR; PRIORITY JOURNAL; SCLERODERMA; SMALL FOR DATE INFANT; SYNCYTIOTROPHOBLAST; SYSTEMIC SCLEROSIS; VASCULAR DISEASE;

ACTINS; ADULT; ANGIOGENESIS INDUCING AGENTS; BIOPSY; CONNECTIVE TISSUE GROWTH FACTOR; FEMALE; FIBROSIS; HUMANS; PLACENTA; PREGNANCY; PREGNANCY COMPLICATIONS; SCLERODERMA, SYSTEMIC;

EID: 75749152990     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/ard.2009.107623     Document Type: Article

References (17)

1. Varga J, Abraham D. Systemic sclerosis: a prototypic multisystem fibrotic disorder. J Clin Invest 2007;117:557-67.
2. Steen VD. Pregnancy in women with systemic sclerosis. Obstet Gynecol 1999;94:15-20.
3. Miniati I, Guiducci S, Mecacci F, et al. Pregnancy in systemic sclerosis. Rheumatology (Oxford) 2008;47(Suppl 3):iii16-8.
4. Chung L, Flyckt RL, Colón I, et al. Outcome of pregnancies complicated by systemic sclerosis and mixed connective tissue disease. Lupus 2006;15:595-9.
5. Doss BJ, Jacques SM, Mayes MD, et al. Maternal scleroderma: placental findings and perinatal outcome. Hum Pathol 1998;29:1524-30.
6. Labarrere CA, Catoggio LJ, Mullen EG, et al. Pregnancy lesions in maternal autoimmune diseases. Am J Reprod Immunol Microbiol 1986;12:78-86.
7. Papakonstantinou K, Hasiakos D, Kondi-Paphiti A. Clinicopathology of maternal scleroderma. Int J Gynaecol Obstet 2007;99:248-9.
8. Kaufmann P, Mayhew TM, Charnock-Jones DS. Aspects of human fetoplacental vasculogenesis and angiogenesis. II. Changes during normal pregnancy. Placenta 2004;25:114-26.
9. Mayhew TM, Charnock-Jones DS, Kaufmann P. Aspects of human fetoplacental vasculogenesis and angiogenesis. III. Changes in complicated pregnancies. Placenta 2004;25:127-39.
10. Kumazaki K, Nakayama M, Suehara N, et al. Expression of vascular endothelial growth factor, placental growth factor, and their receptors Flt-1 and KDR in human placenta under pathological conditions. Hum Pathol 2002;33:1069-77.
11. Distler O, Distler JH, Scheid A, et al. Uncontrolled expression of vascular endothelial growth factor and its receptors leads to insufficient skin angiogenesis in patients with systemic sclerosis. Circ Res 2004;95:109-16.
12. LeRoy EC, Black C, Fleischmajer R, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988;15:202-5.
13. Steen VD, Medsger TA Jr. Fertility and pregnancy in women with systemic sclerosis. Arthritis Rheum 1999;42:763-8.
14. Guiducci S, Giacomelli R, Matucci-Cerinic M. Vascular complications of scleroderma. Autoimmun Rev 2007;6:520-3.
15. Langston C, Kaplan C, Macpherson T, et al. Practice guideline for examination of the placenta: developed by the Placental Pathology Practice Guideline Development Task Force of the College of American Pathologists. Arch Pathol Lab Med 1997;121:449-76.
16. Salafia CM, Pezzullo JC, López-Zeno JA, et al. Placental pathologic features of preterm preeclampsia. Am J Obstet Gynecol 1995;173:1097-105.
17. Manetti M, Neumann E, Milia AF, et al. Severe fibrosis and increased expression of fibrogenic cytokines in the gastric wall of systemic sclerosis patients. Arthritis Rheum 2007;56:3442-7.